Padua Prediction Score for VTE Risk in Thoracic Surgery Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAl-Nahrain University
About this trial
The goal of this observational study is to assess the predictive accuracy of the Padua Prediction Score (PPS) for venous thromboembolism (VTE) risk in thoracic surgery patients.
The study aims to answer the following question:
Does the PPS provide a more accurate prediction of VTE risk?
Participants will:
Have their VTE risk assessed using the PPS during their hospital admission.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who have undergone preoperative Padua Prediction Score assessment.
Inpatients with a hospital stay over 3 days
Written informed consent obtained from patients or their legal guardians.
Availability for postoperative follow-up to assess outcomes like LEVT development or related complications.
Disqualifiers
Preexisting LEVT or pulmonary embolism.
Severe Coagulopathy: Patients with inherited or acquired bleeding disorders (e.g., hemophilia, advanced liver disease).
receiving any anticoagulation therapy for any reason.
patients who did not undergo a postoperative D-dimer test.
Trial population
The study will focus on adult patients undergoing thoracic surgery at a single center in Iraq.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Incidence of Venous Thromboembolism (VTE) Episodes in Patients
symptomatic or asymptomatic, confirmed by instrumental diagnostics.
Time frame
In-Hospital Phase (average of 10 days through discharge); Post-Discharge Follow-Up: Day 7, Day 15, and Day 302
Padua Prediction Score
A total score that ranges from 0 to 20. 4 or higher indicates a significant likelihood of developing VTE.
Time frame
Day 1 preoperative (one day prior to surgery)Secondary outcomes
1
Incidence of Symptomatic Pulmonary Embolism in Patients
symptomatic pulmonary embolism confirmed by perfusion isotope scanning or CT pulmonary angiography.
Time frame
In-Hospital Phase (average of 10 days through discharge); Post-Discharge Follow-Up: Day 7, Day 15, and Day 302
Rate of Recurrent Deep Vein Thrombosis (DVT) in Patients
A new episode of deep vein thrombosis occurs after the initial diagnosis with clinical symptoms (such as leg pain, swelling, redness, or tenderness) and is confirmed through instrumental diagnostics (e.g., ultrasound, CT venography, MRI).
Time frame
Post-Discharge Follow-Up: Day 7, Day 15, and Day 30Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov